The influence on the secretory IgA antibody levels in lactating women of oral typhoid and parenteral cholera vaccines given alone or in combination. 1989

M Hahn-Zoric, and B Carlsson, and F Jalil, and L Mellander, and R Germanier, and L A Hanson
Department of Clinical Immunology, University of Göteborg, Sweden.

41 lactating Pakistani women were vaccinated orally with Salmonella typhi vaccine alone or in combination with parenteral Vibrio cholerae whole cell vaccine, in order to study the possible difference in the secretory response after live and inactivated vaccines. The antibody response in saliva, milk and serum was recorded using the enzyme-linked immunosorbent assay, ELISA. All had prevaccination antibody levels against the 2 vaccines. The live S. typhi vaccine gave a serum IgG and IgA response but did not influence the IgM levels. Salivary or milk secretory IgA (SIgA) antibody levels showed both increases and decreases but in most cases remained unchanged. Even if the vaccine was given in enteric coated capsules, the milk and salivary SIgA response was more often decreased than increased, although somewhat higher serum IgG levels were attained with this preparation. Parenteral cholera vaccination enhanced both serum and SIgA milk antibody response. Combination of the 2 vaccines did not have any untoward effect on the antibody response in serum or in secretions against V. cholerae or S. typhi LPS. The results show that an oral vaccine often induces a rather poor, or even negative mucosal antibody response, while a parenteral vaccine provokes a substantial SIgA response in individuals orally primed by natural exposure. This is in agreement with our previous findings with oral and parenteral poliovirus vaccines in this population.

UI MeSH Term Description Entries
D007071 Immunoglobulin A, Secretory The principle immunoglobulin in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. The complete molecule (around 400 kD) is composed of two four-chain units of IMMUNOGLOBULIN A, one SECRETORY COMPONENT and one J chain (IMMUNOGLOBULIN J-CHAINS). Colostral IgA,IgA, Exocrine,IgA, Secretory,SIgA,Secretory IgA,Secretory Immunoglobulin A,Exocrine IgA,IgA, Colostral
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D008895 Milk, Human Milk that is produced by HUMAN MAMMARY GLANDS. Breast Milk,Human Milk,Milk, Breast
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D014436 Typhoid-Paratyphoid Vaccines Vaccines used to prevent TYPHOID FEVER and/or PARATYPHOID FEVER which are caused by various species of SALMONELLA. Attenuated, subunit, and inactivated forms of the vaccines exist. Paratyphoid Vaccine,Typhoid Vaccine,Vaccines, Paratyphoid,Vaccines, Typhoid,Paratyphoid Vaccines,Typhoid Paratyphoid Vaccines,Typhoid Vaccines,Vaccine, Paratyphoid,Vaccine, Typhoid,Vaccines, Typhoid-Paratyphoid
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated

Related Publications

M Hahn-Zoric, and B Carlsson, and F Jalil, and L Mellander, and R Germanier, and L A Hanson
January 1977, Scandinavian journal of immunology,
M Hahn-Zoric, and B Carlsson, and F Jalil, and L Mellander, and R Germanier, and L A Hanson
April 1997, The Journal of infectious diseases,
M Hahn-Zoric, and B Carlsson, and F Jalil, and L Mellander, and R Germanier, and L A Hanson
November 1977, Acta paediatrica Scandinavica,
M Hahn-Zoric, and B Carlsson, and F Jalil, and L Mellander, and R Germanier, and L A Hanson
January 1988, International archives of allergy and applied immunology,
M Hahn-Zoric, and B Carlsson, and F Jalil, and L Mellander, and R Germanier, and L A Hanson
January 1970, Progress in immunobiological standardization,
M Hahn-Zoric, and B Carlsson, and F Jalil, and L Mellander, and R Germanier, and L A Hanson
January 1979, Journal of biological standardization,
M Hahn-Zoric, and B Carlsson, and F Jalil, and L Mellander, and R Germanier, and L A Hanson
June 1992, Magnesium research,
M Hahn-Zoric, and B Carlsson, and F Jalil, and L Mellander, and R Germanier, and L A Hanson
January 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene,
M Hahn-Zoric, and B Carlsson, and F Jalil, and L Mellander, and R Germanier, and L A Hanson
January 1956, Acta pathologica et microbiologica Scandinavica,
M Hahn-Zoric, and B Carlsson, and F Jalil, and L Mellander, and R Germanier, and L A Hanson
January 1988, Allergologia et immunopathologia,
Copied contents to your clipboard!